UCB (PHARMA) IRELAND LIMITED

UCB (Pharma) Ireland Limited is the Irish arm of the global biopharmaceutical leader dedicated to improving the lives of people living with neurological and autoimmune conditions. By harnessing cutting-edge science and a patient-centred approach, UCB develops and delivers medicines that address severe, often unmet medical needs, helping patients achieve a better quality of life.

A key pillar of the business is UCBCares®, a personalised support service that assists patients and healthcare professionals throughout the treatment journey with a UCB medicine. The company also invests in future-focused innovation through UCB Ventures, backing pioneering technologies and start-ups that have the potential to transform care for severe diseases. Sustainability is woven into every decision, with net-zero targets validated by the Science Based Targets initiative and a commitment to empowering women of child-bearing age.

Through its blend of scientific expertise, compassionate support and forward-looking investment, UCB (Pharma) Ireland Limited strives to bring breakthrough therapies to Irish patients and contribute to a healthier, more sustainable future.